Milk Types and Fish Oil in 9- to 12-Month-Old Infants
Not Applicable
Completed
- Conditions
- ObesityMetabolic SyndromeGrowthBlood PressureCardiovascular Disease
- Registration Number
- NCT00379171
- Lead Sponsor
- University of Copenhagen
- Brief Summary
The objective of this intervention study is to examine the effect of whole cow's milk versus infant formula as primary milk sources with or without supplements of n-3 LCPUFA for growth, nutritional status, development, risk factors for later diseases and the impact on the intestinal microbiota and inflammation in 9 - 12 months old infants.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Singleton infants
- Born >= 37 wk of gestation
- Birth weight > 2500g
- >= 5th percentile for gestational age
- A 5-min Apgar score >= 7
- Daily consumption of cow's milk or formula
Exclusion Criteria
- No major complications at birth or in fetal life
- No chronic diseases
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Primary Outcome Measures
Name Time Method Growth Body composition (weight, length, knee-heel-length, waist, head, and arm circumference, skin fold measurements). IGF-I IGFBP-3 Insulin - glucose metabolism (HOMA index). Urea Nitrogen Albumin C-peptide Amino Acids Erythrocyte fatty acid composition Blood pressure Lipid Profile Heart Rate Variability (HRV) In vitro cytokine production from stimulated full blood (IL-10, IFN-gamma, TNF-alpha) Plasma IgE, IL-2R, and CRP
- Secondary Outcome Measures
Name Time Method Plasma concentrations of cholesterol and triglycerides Allergy status Cognitive test ("The infant means-end problem solving test") Iron status (hemoglobin, ferritin and transferrin receptors) Feces samples: Calprotectin, IgA and composition of the intestinal microbiota